Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccine Liability: Supreme Court Justices Question Manufacturer “Motivation,” Comparative Safety

Executive Summary

If the pharmaceutical industry is expecting a Supreme Court decision declaring blanket federal preemption of vaccine-related design defect claims, it must hope that questions raised by Supreme Court Justice Sonia Sotomayor in a vaccine liability case do not portend the views of the court’s majority.

You may also be interested in...



High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption

The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.

High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption

The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.

Supreme Court Immunizes Vaccine Manufacturers Against Design Defect Claims

In a 6-2 decision, the high court rules that manufacturers need not show that it would have been impossible to make a safer product and that plaintiffs' injuries were, therefore, unavoidable.

Related Content

Topics

UsernamePublicRestriction

Register

LL043624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel